Lantern Pharma LTRN - 옵션 체인 | ADVFN

다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

Lantern Pharma Inc (LTRN)

3.89

0.00

(0.00%)

마감 06 3월 6:00AM

3.89

0.00

( 0.00% )

시간외 단일가: 9:26PM

LTRN 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
1.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
2.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
3.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
4.00	0.70	0.70	0.70	0.70	0.00	0.00 %	0	43	-
5.00	0.20	0.20	0.20	0.20	0.00	0.00 %	0	16	-
6.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.00	0.00	1.00	0.00	0.00	0.00	0.00 %	0	0	-
8.00	0.00	2.95	0.00	0.00	0.00	0.00 %	0	0	-
9.00	0.00	2.95	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
11.00	0.00	2.95	0.00	0.00	0.00	0.00 %	0	0	-

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
1.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
2.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
3.00	0.00	2.00	0.00	0.00	0.00	0.00 %	0	0	-
4.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
6.00	1.05	4.00	0.00	2.525	0.00	0.00 %	0	0	-
7.00	1.90	3.60	1.25	2.75	0.00	0.00 %	0	0	-
8.00	3.70	5.90	2.85	4.80	0.00	0.00 %	0	0	-
9.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
11.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
AGMHAGM Group Holdings Inc	US$ 0.1755 (71.55%)	151.47M
GVVisionary Holdings Inc	US$ 6.25 (69.15%)	38.7M
PSTVPlus Therapeutics Inc	US$ 0.583 (66.57%)	38.73M
AFRIForafric Global PLC	US$ 14.13 (58.94%)	9
HFBLHome Federal Bancorp Inc of Louisiana	US$ 19.82 (53.41%)	63
GEOSGeospace Technologies Corporation	US$ 5.01 (-32.21%)	1
RANDRand Capital Corporation	US$ 17.01 (-23.96%)	51
BSCUInvesco BulletShares 2030 Corporate Bond ETF	US$ 13.01 (-21.53%)	1
PODCPodcastOne Inc	US$ 1.40 (-20.00%)	101
MDBMongoDB Inc	US$ 216.00 (-18.22%)	196.91k
AGMHAGM Group Holdings Inc	US$ 0.1756 (71.65%)	151.47M
PSTVPlus Therapeutics Inc	US$ 0.581 (66.00%)	38.75M
GVVisionary Holdings Inc	US$ 6.29 (70.23%)	38.73M
CUTRCutera Inc	US$ 0.1458 (26.23%)	27.02M
ADTXAditxt Inc	US$ 0.0643 (8.25%)	24.41M

Monksdream

Monksdream 6 월 전

anabu9

anabu9 7 월 전

Finally an UP day. 'hope institutions will see this nugget soon

FALCON1

FALCON1 7 월 전

https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri
https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation

dinogreeves

dinogreeves 10 월 전

🕳️ 1 🪦 1 ⚰️ 1

Monksdream

Monksdream 10 월 전

Monksdream

Monksdream 11 월 전

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc

dinogreeves

dinogreeves 11 월 전

Monk, take a look at ANV*S. Data is due sometime in April, Parkinsons and Alzheimers. They just did a private placement on Friday and another one today to an institutional investor. "Subject to Certain Conditions". Looks like April is go time.

dinogreeves

dinogreeves 12 월 전

I think we can revisit the high again hopefully this week. Been here since 7.20

spartex

spartex 12 월 전

10-K filing, Earnings Webcast, Presentation in link below from LTRN company website

https://ir.lanternpharma.com/news-events/press-releases/detail/150/lantern-pharma-reports-fourth-quarter-fiscal-year-2023

Monksdream

Monksdream 12 월 전

dinogreeves

dinogreeves 12 월 전

Another very good day today.

Monksdream

Monksdream 12 월 전

LTRN 10Q due 3/18

dinogreeves

dinogreeves 12 월 전

Very good move on Friday.

🪦 1 ☠️ 1 ⚰️ 1 ⚱️ 1

dinogreeves

dinogreeves 12 월 전

This company will see 3 digit dollars, how soon? All depends on just one science behind their Artificial Intelligence to decode one cancer indication the rest will be history.

dinogreeves

dinogreeves 12 월 전

This is going to have one heck of a run.

Tremors!

Tremors! 12 월 전

Will they break 10.00!??

Roily23

Roily23 1 년 전

Roily23

Roily23 1 년 전

AI is the next .com and AI's application in medicine and pharma will be a game changer.

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. It develops LP-100 for treatment in combination with the class of anticancer agent known as PARP inhibitors. The company also develops LP-300 as a combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; and LP-284, a novel small molecule and DNA damaging agent for the treatment of mantle cell lymphoma and double hit lymphoma. In addition, it offers LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관